Evidence map›Paper›PMID 33938228›Full record

ArticleJournal of the American Heart Association2021

Aerobic Exercise Restores Aging-Associated Reductions in Arterial Adropin Levels and Improves Adropin-Induced Nitric Oxide-Dependent Vasorelaxation.

Shumpei Fujie, Natsuki Hasegawa, Naoki Horii, Masataka Uchida, Kiyoshi Sanada, Takafumi Hamaoka, Jaume Padilla, Luis A Martinez-Lemus, Seiji Maeda, Motoyuki Iemitsu

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Protective roles of adropin in neurological disease.American journal of physiology. Cell physiology · 2023
    Review
  13. Role of adropin in arterial stiffening associated with obesity and type 2 diabetes.American journal of physiology. Heart and circulatory physiology · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Shumpei FujieFaculty of Sport and Health Science Ritsumeikan University Shiga Japan.
Natsuki HasegawaResearch Organization of Science and Technology Ritsumeikan University Shiga Japan.
Naoki HoriiFaculty of Sport and Health Science Ritsumeikan University Shiga Japan.
Masataka UchidaFaculty of Sport and Health Science Ritsumeikan University Shiga Japan.
Kiyoshi SanadaFaculty of Sport and Health Science Ritsumeikan University Shiga Japan.
Takafumi HamaokaSports Medicine for Health Promotion Tokyo Medical University Tokyo Japan.
Jaume PadillaDalton Cardiovascular Research Center University of Missouri MO.
Luis A Martinez-LemusDalton Cardiovascular Research Center University of Missouri MO.
Seiji MaedaFaculty of Sport and Health Sciences University of Tsukuba Ibaraki Japan.
Motoyuki IemitsuFaculty of Sport and Health Science Ritsumeikan University Shiga Japan.
Ritsumeikan University · JPUniversity of Missouri · USTokyo Medical University · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Adropin is a peptide hormone that promotes nitric oxide (NO) production via activation of endothelial NO synthase (eNOS) in endothelial cells. Its circulating levels are reduced with aging and increased with aerobic exercise training (AT). Using a mouse model, we hypothesized that AT restores aging-associated reductions in arterial and circulating adropin and improves adropin-induced NO-dependent vasorelaxation. Further, we hypothesized these findings would be consistent with data obtained in elderly humans. Methods and Results In the animal study, 50-week-old SAMP1 male mice that underwent 12 weeks of voluntary wheel running, or kept sedentary, were studied. A separate cohort of 25-week-old SAMP1 male mice were used as a mature adult sedentary group. In the human study, 14 healthy elderly subjects completed an 8-week AT program consisting of 45 minutes of cycling 3 days/week. In mice, we show that advanced age is associated with a decline in arterial and circulating levels of adropin along with deterioration of endothelial function, arterial NO production, and adropin-induced vasodilation. All these defects were restored by AT. Moreover, AT-induced increases in arterial adropin were correlated with increases in arterial eNOS phosphorylation and NO production. Consistently with these findings in mice, AT in elderly subjects enhanced circulating adropin levels and these effects were correlated with increases in circulating nitrite/nitrate (NOx) and endothelial function. Conclusions Changes in arterial adropin that occur with age or AT relate to alterations in endothelial function and NO production, supporting the notion that adropin should be considered a therapeutic target for vascular aging. Registration URL: https://www.umin.ac.jp; Unique identifier: UMIN000035520.

Indexed as

AgingAnimalsAorta, ThoracicEndothelial CellsGene Expression RegulationIntercellular Signaling Peptides and ProteinsMaleMiceNitric OxidePhysical Conditioning, AnimalPhysical EnduranceRNAVascular StiffnessVasodilationEnho protein, mouseIntercellular Signaling Peptides and ProteinsNitric OxideRNAadropinagingexercise trainingnitric oxidevasodilation

Identifiers

PMID33938228
PMCPMC8200711
OpenAlexW3158648591

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.